| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 |
| Total Revenue | 895 | 591 | 199 |
| Cost of Revenue | 466 | 279 | 119 |
|
| Gross Profit | 429 | 312 | 79 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
| Selling General and Administrative | 731 | 1,149 | 1,000 |
| Non Recurring |
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (302) | (837) | (921) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
| Earnings Before Interest And Taxes | (302) | (837) | (921) |
| Interest Expense | 82 | 68 | 69 |
| Income Before Tax | (384) | (906) | (990) |
| Income Tax Expense |
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (384) | (906) | (990) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (384) | (906) | (990) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($384) | ($906) | ($990) |
1.48% Nasdaq 
Income Statement
